Skip to content

Effectiveness of Rebound Therapy in Parkinson's Patients

Effectiveness of Rebound Therapy on Balance and Gait in Parkinson's Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05855161
Enrollment
17
Registered
2023-05-11
Start date
2023-04-10
Completion date
2023-12-10
Last updated
2023-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Parkinson's disease, rebound therapy, task oriented training, balance and walking performance

Brief summary

Today, physiotherapy approaches in Parkinson's Disease (PD) form the basis of optimal treatment together with medical and surgical treatment. It is stated that various rehabilitation interventions may be effective in the field of physiotherapy. The frequently preferred among these rehabilitation interventions is the conventional treatment approach. In the conventional treatment, various exercises are preferred to improve balance and walking, as well as stretching and strengthening. On the other hand, rebound therapy require strong integration of the neuromuscular system and provide more active use of lower extremity muscle strength. Rebound therapy have been shown to be effective in improving balance in many neurological disease groups, but there is very little study on rebound therapy in PD. It was shown that rebound therapy improve proprioceptive sense, joint range of motion and quality of life. On the other hand, no study has been found showing its effect on balance and walking. Therefore, there is a need to investigate the effectiveness of rebound therapy on balance and walking.

Detailed description

This study is a randomized controlled study. The patients will be randomly divided into two groups as rebound and control. The rebound group will perform exercises on a trampoline, consisting of 15 minutes of trunk and extremity stretching, 10 minutes of walking, and approximately 30 minutes of task-oriented exercises, twice a week for six weeks. While the control group will follow the same program as the rebound group, they will only perform task-oriented exercises on a stable surface, unlike the rebound group. As the outcome measures, disease severity and disability, balance, and gait performance will be evaluated.

Interventions

Participants will receive exercise-based training on a trampoline

OTHERExercises on a stable surface

Participants will receive exercise-based training on a stable surface

Sponsors

Gazi University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Two groups as rebound group and control group

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 40-80 years of age * Having diagnosed with Parkinson's Disease by a specialist physician * Having between 1-3 stages according to the Hoehn and Yahr Scale * Mini-Mental Test score more than or equal 24

Exclusion criteria

\- Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results

Design outcomes

Primary

MeasureTime frameDescription
Static Balance- BaselineAssessment will be conducted before the interventionAssessment will be made with the Biodex Balance System
Static Balance- Post interventionAssessment will be conducted immediately after the interventionAssessment will be made with the Biodex Balance System
Gait speed- BaselineAssessment will be conducted before the interventionAssessment will be made with the BTS G-Walk, (BTS SpA, Via della Croce Rossa, 11 Padova, Italy; SN: 0213-0378) during gait
Gait speed- Post interventionAssessment will be conducted immediately after the interventionAssessment will be made with the BTS G-Walk, (BTS SpA, Via della Croce Rossa, 11 Padova, Italy; SN: 0213-0378) during gait
Knee strength- BaselineAssessment will be conducted before the interventionAssessment will be made with an isokinetic dynamometer (Cybex Humac Norm Testing and Rehabilitation System, CSMI, USA)
Knee strength-Post interventionAssessment will be conducted immediately after the interventionAssessment will be made with an isokinetic dynamometer (Cybex Humac Norm Testing and Rehabilitation System, CSMI, USA)

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026